These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2863538)

  • 1. Reversal of slow-wave sleep by benzodiazepine antagonist Ro 15-1788.
    Ziegler G; Ludwig L; Fritz G
    Lancet; 1985 Aug; 2(8453):510. PubMed ID: 2863538
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the benzodiazepine antagonist Ro 15-1788 on flunitrazepam-induced sleep changes.
    Gaillard JM; Blois R
    Br J Clin Pharmacol; 1983 May; 15(5):529-36. PubMed ID: 6134542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benzodiazepine antagonist, Ro 15-1788, increases REM and slow wave sleep in the dog.
    Wauquier A; Ashton D
    Brain Res; 1984 Aug; 308(1):159-61. PubMed ID: 6434149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ro 15-1788 antagonizes the effects of diazepam in man without affecting its bioavailability.
    O'Boyle C; Lambe R; Darragh A; Taffe W; Brick I; Kenny M
    Br J Anaesth; 1983 Apr; 55(4):349-56. PubMed ID: 6404290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505: inverse agonism, tolerance, and rebound.
    Gentil V; Tavares S; Gorenstein C; Bello C; Mathias L; Gronich G; Singer J
    Psychopharmacology (Berl); 1990; 100(1):54-9. PubMed ID: 2104987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation in man of the efficacy of a benzodiazepine antagonist, Ro 15-1788.
    Darragh A; Lambe R; Scully M; Brick I; O'Boyle C; Downe WW
    Lancet; 1981 Jul; 2(8236):8-10. PubMed ID: 6113428
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of adenosine accumulation by a CNS benzodiazepine antagonist (Ro 15-1788) and a peripheral benzodiazepine receptor ligand (Ro 05-4864).
    Morgan PF; Lloyd HG; Stone TW
    Neurosci Lett; 1983 Oct; 41(1-2):183-8. PubMed ID: 6417576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of the efficacy and tolerance of a benzodiazepine antagonist (Ro 15-1788)].
    Rouiller M; Forster A; Gemperle M
    Ann Fr Anesth Reanim; 1987; 6(1):1-6. PubMed ID: 3107442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of the benzodiazepine antagonist Ro 15-1788 in humans after sleep withdrawal.
    Emrich HM; Sonderegger P; Mai N
    Neurosci Lett; 1984 Jun; 47(3):369-73. PubMed ID: 6433243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benzodiazepine antagonist, Ro 15-1788 does not decrease ethanol withdrawal convulsions in rats.
    Little HJ; Taylor SC; Nutt DJ; Cowen PJ
    Eur J Pharmacol; 1985 Jan; 107(3):375-7. PubMed ID: 3920059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of a benzodiazepine antagonist Ro 15-1788 in the presence of stable concentrations of midazolam.
    Lauven PM; Schwilden H; Stoeckel H; Greenblatt DJ
    Anesthesiology; 1985 Jul; 63(1):61-4. PubMed ID: 2861765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine antagonist Ro 15-1788 counteracts the prolactin-lowering effects of other benzodiazepines in rats.
    Lotz W
    Neuroendocrinology; 1982; 35(1):32-6. PubMed ID: 6287328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the specific benzodiazepine antagonist, Ro 15-1788, in studies of physiological dependence on benzodiazepines.
    Cumin R; Bonetti EP; Scherschlicht R; Haefely WE
    Experientia; 1982 Jul; 38(7):833-4. PubMed ID: 6809488
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction of the benzodiazepine antagonists, CGS 8216 and Ro 15-1788, with central adenosine A-1 receptors.
    Williams M; Risley EA
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):50-3. PubMed ID: 6299218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of flunitrazepam on memory and their reversal by two antagonists.
    Gentil V; Gorenstein C; Camargo CH; Singer JM
    J Clin Psychopharmacol; 1989 Jun; 9(3):191-7. PubMed ID: 2500462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological aspects of benzodiazepine antagonists, Ro 15-1788 and Ro 15-3505.
    Gath I; Weidenfeld J; Collins GI; Hadad H
    Br J Clin Pharmacol; 1984 Oct; 18(4):541-7. PubMed ID: 6435655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine antagonist (RO 15-1788) in ethanol intoxication: a pilot study.
    Scollo-Lavizzari G; Matthis H
    Eur Neurol; 1985; 24(5):352-4. PubMed ID: 3932075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of the benzodiazepine antagonist RO 15-1788].
    Ellmauer S; Müller H; Dick W
    Anaesthesist; 1988 Jul; 37(7):432-9. PubMed ID: 3137835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of the benzodiazepine antagonist Ro 15-1788 after "general anaesthetic" doses of benzodiazepines in mice.
    Little HJ; Bichard AR
    Br J Anaesth; 1984 Oct; 56(10):1153-60. PubMed ID: 6148095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.